Matt, Chris, and Don discuss a new treatment for lung cancer (immunotherapy), the gang discusses a controversy that occurred when a large clinical trial decided to change its endpoint, and Chris dives into the world of linguistics (again). Journal club article: Pembrolizumab lung cancer trial
Episode 23 - A breakthrough for lung cancer treatment? | Free Associations podcast - Listen or read transcript on Metacast
